Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Disparities in Respiratory Diseases
U.S. Pharmacist, 07/27/09
Pal S et al. – According to the 2007 National Health Interview Survey (NHIS), 2% of adults have ever been diagnosed with emphysema; 11%, with asthma; and 3%, with chronic bronchitis (CB). Women are more likely to be diagnosed with asthma or CB, and men are more likely to be diagnosed with emphysema. Hispanic adults have lower rates of asthma than non–Hispanic white adults, and lower rates of CB than non–Hispanic white adults or black adults. Adults with at least a bachelor's degree are less likely to be diagnosed with emphysema or CB compared with adults with less education. Adults in poor families have higher percentages of emphysema, asthma, and CB than those in families that are better off.
Related Articles
Effects of aging on the adaptive immune response to respiratory virus infections
Aging Health, 11/23/09
Relevance Score: 70%
Associations between decay-accelerating factor polymorphisms and allergic respiratory diseases
Clinical and Experimental Allergy, 11/24/09
Relevance Score: 68%
CAM and Respiratory Disease
Nutrition in Clinical Practice, 10/30/09
Relevance Score: 68%
Quantitation of Respiratory Viruses in Relation To Clinical Course in Children With Acute Respiratory Tract Infections
The Pediatric Infectious Disease Journal, 10/29/09
Relevance Score: 68%
Increased relative mortality in women with severe oxygen-dependent chronic obstructive pulmonary disease
Chest, 10/07/09
Relevance Score: 67%
Today in Major Studies...keeping you current
Receive free subspecialty "5-minute updates" via email
Evaluation of Treatment Satisfaction in Children with Allergic Disease Treated with an Antihistamine: An International, Non-Interventional, Retrospective Study
Clinical Drug Investigation, 12/11/09
Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America
Sanofi-aventis, 12/10/09
Allos Therapeutics' FOLOTYN Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneous T-Cell Lymphoma
Allos Therapeutics, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


